“asthma” Archives

Entry Author Date Location
Pfizer Hands Back Rigel Drug 05/06/11 San Francisco
Isis Spinoff Altair Therapeutics Shut Down, After Mid-Stage Asthma Study Fails 02/03/11 San Diego
FDA Approves Sunovion Schizophrenia Drug 10/29/10 Boston
Amylin Regroups From FDA Smackdown, CalciMedica Plans Trial of New Anti-Immune Drug, FDA Gives CareFusion Recall Highest Priority, & More San Diego Life Science News 10/21/10 San Diego
Boston Scientific to Inhale Asthmatx in $194M Buyout 09/20/10 Boston
NKT Brings In $4M 08/25/10 Boston
How to Find Balance in Biotech, Between Owning It All or Finding a Partner 06/16/10 San Diego
Acton Pharmaceuticals Snares $15M for Inhaled Asthma Drug 01/06/10 Boston
Novartis Parts Ways with Idera Pharma 11/25/09 Boston
Isis Spinoff Altair Therapeutics Closes $17M Venture Round For Asthma Drug 11/12/09 San Diego
Pulmatrix Scores $30M To Block All Sorts of Bugs That Make People Sick in the Lungs 11/02/09 Boston
AstraZeneca Plans Local Job Cuts, Report Says 09/11/09 Boston
Pulmatrix, With One Drug for Multiple Bugs, Aims to Fundamentally Change Flu Treatment 06/09/09 Boston
NKT Therapeutics Aims For Severe Asthma, Targeting Natural Killer T Cells 05/18/09 Boston
Altair Therapeutics Changes CEO 05/14/09 San Diego
Calistoga Raises $30M to Develop Drugs for Cancer, Inflammation 05/05/09 Seattle
Axikin Raises $3M After Spinning Out From Actimis 01/22/09 San Diego
KaloBios Gets $12M Genzyme, Baxter 12/22/08 Boston
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says 11/13/08 Boston
Calistoga Builds Cancer Drug Strategy, Hires First CEO, Carol Gallagher 10/08/08 Seattle
MPM Capital, World’s Biggest Healthcare VC Fund, Balances Startups With Stocks 10/07/08 Boston
Idera Receives Milestone Payment from Novartis For Asthma and Allergy Collaboration 09/02/08 Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge 08/14/08 Boston
Resolvyx Experiment Shows Fish-Oil Derivative Tamps Down Asthma, Inflammation 07/03/08 Boston
Page 2 of 2 « previous page